For release content, please refer to the attachment.
Recommended Reading
-
Bagsværd, Denmark, 07 September 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Read More -
STEP Young data show 40.4% of children treated with semaglutide and lifestyle modification were no longer classified as having obesity.
Read More